The race to build virtual cells has become one of the most ambitious scientific efforts of our time. Most programs pursue a similar strategy: generate massive biological atlases, perform millions of perturbation experiments, collect vast amounts of cellular data, and train increasingly sophisticated AI models to predict how cells respond.

This approach assumes that sufficiently large datasets will eventually reveal causality.

But a cell is not a database.

It is a continuously evolving physical system composed of interacting proteins, metabolites, membranes, signalling networks, and energy flows. To compute a cell requires more than describing its components. It requires computing how biological mechanisms emerge, propagate, and interact through time.

The race to build a virtual cell is ultimately not a race for more data. It is a race to compute causality.

OmnigeniQ is taking a fundamentally different approach. Rather than learning biology from observation, we are building the first deterministic virtual cell by computing the physics govern biology.

Our aim is to scale this to build the world's first holographic twin of human physiology to make healthcare preventative, predictive and precise.

Why work with us

Team

OmnigeniQ’s co-founders are a multidisciplinary team with expertise across computational biology, AI/ML, quantum-informed modelling, regulatory strategy, drug development, software development, and commercial execution.

Our team are pioneers in recursive computation, deterministic intelligence, and new computational substrates for scientific reasoning. Our work spans advanced mathematics, causal modelling, first-principles biology, protein and matter compilation, mechanistic discovery, and organism-scale simulation. We believe these capabilities represent a new path toward intelligence: one based on computation of mechanism rather than prediction of patterns.